Purpose: With the ability to solve problems of standard medicine, nanotechnology is presently an innovative technology in advanced pharmaceutical delivery. A wide range of nanocarriers, including lipid-based systems, polymeric nanoparticles, self-assembled structures, and functionalized nanomaterials, provides diverse platforms for the delivery of a range of medicaments, extending from pure substances to genetic therapies like siRNA 4. Methods: This review highlights the application of nanotechnology-based systems in drug delivery, including their role in tumour research, bronchial delivery, oral therapeutic formulations, and even integrated techniques such as diagnostic-guided therapy, which blends the assessment and cure. Results: By presenting the accurate transfer and managed release, nanoparticles can strengthen the therapeutic solubility, durability, and uptake while facilitating the therapeutic results and minimizing the side effects2,3.An additional benchmark has been given to Antitumor therapy, where site-specific nanoparticles and reaction-prone system reduce the harm to nourishing cells while strengthening the treatment reproducibility3,8. Green and sustainable nanomaterials focus on the advancement towards reliable, planet-friendly, and user-friendly formulations5. Conclusion: Regardless of these new methods, hardships remain in assuring large-batch production, prolonged safety, loss prevention, and sandardization approval6. Currently, investigation prevails to more evident technological approaches, plan efficient carriers, and analyse future opportunities where nano-drug delivery could alter the healthcare on an international scale7 . Keywords: nanocarriers, bioavailability, diagnostic-guided therapy, targeted delivery, novel drug delivery system.
Chandola et al. (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: